HCLS/ How digital therapy benefits patients, providers, and the health ecosystem

A combination of AI and sensor technologies can augment existing therapy to benefit both patients and healthcare payers Accumulated patient data enables the creation of individualized solutions. It also allows healthcare providers to optimize treatment with a goal of better outcomes and lower costs.

Life sciences companies are building capabilities commonly found within IT companies, and vice versa Digital therapy is a useful addition to current standard care. For the life sciences industry, it enables new “beyond the pill” business models centered on support services and advice tailored to the patient.

Proven clinical effectiveness and regulatory oversight are providing guardrails to healthcare’s “digital revolution” Digital therapies must undergo clinical studies, show positive health outcomes, and acquire approval to earn credibility among healthcare providers and payers as an accepted medical treatment.

    Download this white paper to learn more

    IBM may use my contact data to keep me informed of products, services, and offerings.

    By email
    By telephone
    By postal mail

    You can withdraw your marketing consent at any time by submitting an opt-out request. Also you may unsubscribe from receiving marketing emails by clicking the unsubscribe link in each email.

    More information on our processing can be found in the IBM Privacy Statement. By submitting this form, I acknowledge that I have read and understand the IBM Privacy Statement

    By submitting this form, you agree to have your contact information passed along for the purpose of following up on your interests and in order receive communications regarding IBM products, services, and events. The data sent will be processed in Canada and provided to IBM who will assume responsibility for processing and Opt-out and Information Removal. For more information, please read our Terms of Use, Privacy, Opt-out & Information Removal below.